key: cord-1000287-jl0yw0id authors: Valdés, P.; Rovira, A.; Guerrero, J.; Morales, Á.; Rovira, M.; Martínez, C. title: Managing the pandemic from the radiology department’s point of view date: 2020-12-31 journal: Radiología (English Edition) DOI: 10.1016/j.rxeng.2020.10.001 sha: 9f58887e6520fc9019a385e56d7c7c35e3d181ee doc_id: 1000287 cord_uid: jl0yw0id The COVID-19 pandemic is forcing our entire society to adopt numerous changes, at least until an effective treatment and/or vaccine becomes widely available. Because COVID-19 is a new disease that has required us to make complex decisions based on scant evidence, the pandemic is having an enormous impact on our health system. Radiology departments play a fundamental role in the management of COVID-19, both in the diagnosis of the disease and in the posterior management of patients. To ensure the safety of patients and healthcare professionals, it is essential to understand the infection so that safe circuits can be implemented. This article summarizes the pathophysiology of COVID-19 infection and explains the measures that radiology departments need to adopt during the pandemic. The Covid-19 infection began as a pneumonia of unknown origin, the first cases being reported in the People's Republic of China in December 2019. 1 Following these first reports, the disease's origin was investigated, the infected population was isolated and other preventive measures were taken. By 7 January 2020, the virus causing the infection had already been isolated 2 : a coronavirus named 2019-nCoV (''new coronavirus detected in 2019''). A few days later, the virus's genome was available 3 and work began on developing tests to detect and diagnose it. The infection spread to 24 countries in under a month. On 11 February 2020, the World Health Organisation called this new infection Covid-19, 4 and just one month later, on 11 March, declared it a worldwide pandemic. Since then, the number of cases has continued to grow at differing rates all over the world, and by the beginning of July 2020, more than 11 million cases and over half a million deaths due to Covid-19 infection had been reported. The first study on cases of Covid-19-induced pneumonia was published in January 2020, involving 41 patients. 5 Since then, the number of publications has grown almost exponentially 6 and, in the field of radiology, not only on cases with pulmonary pathology but also with Covid-19 infection symptoms in different organs and systems. Covid-19 infection continues to pose numerous question marks with regard to epidemiology, virology, response to treatment and the development of an eventual vaccine. The percentage of the population that is immune is also unclear, as is the infection's prevalence outside the highest spikes in incidence. All these data render it very complex to establish recommendations for adapting healthcare processes in radiology departments. Different studies have been carried out on the analysis of the possible impact of Covid-19 infection in the coming months and even years. 7 In view of the difficulty involved in obtaining robust data and the scientific novelty of this infection, analyses are normally based on extrapolating the results of infections produced by similar viruses (other coronaviruses) and on the study of mathematical models based on the different variables available. In this context, conclusions can change as new data are obtained, although certain points do appear to be clear: • The current crisis, with a worldwide pandemic and areas with a very high prevalence, will not disappear in a matter of months. Social distancing and lockdown measures have made it possible to attenuate the number of deaths and infections, although this has also results in a low percentage of immunised people. This means that any approach to phasing out distancing measures (if indeed they are eliminated) must be staggered and slow. • It is not clear how the virus will behave as the seasons change, or if it will mutate in the future. Coronaviruses usually present frequent mutations, 8 although it is not clear that these mutations are taking place faster than expected or that they may impact the disease or its transmission. 9 • There are clinical trials underway to test the efficacy of medical treatments to prevent infection. There are already projects for obtaining vaccines that could be available in the first quarter of 2021. All of these variables have a big influence on the management of the infection and on protection measures. Therefore, the risk of infection continues, which is why a set of safety measures must be maintained in radiology departments. The intensity of these measures should be bolstered when the prevalence of the disease increases, which is to be expected given the possibility of new periodic crises of different intensity. Therefore, all radiologists should be familiar with Covid-19 infection, the SARS-CoV-19 virus and how to prevent infection. This will make it possible to design safe and efficient healthcare pathways. The SARS-CoV-2 virus is a ß genus coronavirus (one of the four genera of coronavirus), with a structure and a genome very similar to other known coronaviruses, such as SARS-CoV and MERS-CoV. 10 It is a virus with a single capsid-enveloped RNA chain of variable morphology (normally rounded and ovoid) with a size of between 60 and 140 nm. 11 The nucleocapsid is protected by a phospholipid envelope into which the surface glycoproteins are inserted (S, HE, M and E). 12 Of the these, the S protein is particularly relevant, as it binds to the cell receptor to allow the virus to enter the cell. 13 The S protein is divided functionally into two domains: S1 (responsible for binding with the cell receptor) and S2 (which permits fusion with the cell membrane). 14 When the virus makes contact with the mucosa cells (nasopharynegeal or respiratory), it binds to the ACE2 Figure 1 General pathophysiology of the Covid-19 infection. The SARS-CoV-2 virus binds to the ACE2 receptor which is located on the surface of certain cells. Once bound to the membrane, it enters the cell and replicates, while also blocking the receptor. The phenomena produced by the virus can be divided into three major groups: those caused by inflammatory response and the immune system, those due to alteration of the angiotensin II system through receptor blockade, and those that are secondary to the coagulopathy and thrombotic phenomena produced by the virus. (angiotensin-converting enzyme 2) receptor. 15 The ACE2 receptor is fundamental in the renin-angiotensinaldosterone system, and in normal conditions is very important in the regulation of homeostasis and the balance of fluids and electrolytes. In this way, besides playing a fundamental role in cell infection, the fact that the virus blocks this receptor could be another of the virus's pathogenesis factors. 16 Once inside the cell, the virus releases its RNA gene into the cellular cytoplasm and replication begins. Once the new viral particles have been formed, they are released in order to re-initiate the cycle. This cycle has been studied, and different therapeutic strategies have been proposed that seek to block the different phases. The ACE2 receptors are involved in many cell tissues, particularly the lungs (type II pneumocytes), heart, blood vessels, kidneys, liver and gastrointestinal tract. 16 Although certain tissues present a greater density of ACE2 receptors than the lungs, Covid-19 infection usually begins in the lungs, 17 and certain tissues with a greater density of ACE2 receptors than the lungs present less or little involvement in Covid-19 infection, as occurs in the gallbladder, the kidneys, seminal glands or testicles. 17 What happens once the infection begins depends on many factors. The pathophysiology of Covid-19 infection is complex and not fully understood, involving several different mechanisms: • Alveolar inflammatory reaction. • Involvement of the capillaries adjacent to the alveoli, which may lead to thrombotic microangiopathy phenomena. • ACE2 receptor blockade. • Coagulation alteration, with hypercoagulability state. • Triggering of an important immune response, in the socalledcytokine storm''. The basic pathophysiology of Covid-19 infection is presented in Figs. 1---3. These figures are adaptations of the series published in references. 12,16,18,19---26 These references should be reviewed in order to further explore the pathophysiology. In summary, the main points that must be considered in order to understand the pathogenesis, radi-ological manifestations and treatment possibilities are the following: • The virus activates inflammatory and immune response in the lungs, with the production of cytokines and interferon and activation of lymphocytes. • This response may be insufficient, so the organism reacts, by amplifying it. This gives rise to the so-calledcytokine stormänd may trigger lymphocyte depletion. • At the same time, a coagulopathy is produced, in which local factors (endothelial aggression), venous stasis and a state of hypercoagulability play a part. • In severe cases, the sum of all these factors gives rise to symptoms that have been called diffuse pulmonary intravascular coagulopathy which, unlike the classic symptoms of disseminated intravascular coagulopathy, does not present thrombocytopenia. 22 Although the virus can affect other organs directly, many of the changes that occur outside the lungs are related more to systemic, thrombotic and microangiopathic involvement than to the direct action of the virus on the specific organ, 22, 27 although in some cases, such as kidney disease, the mechanisms can be more complex. 28 The main form of transmission of the SARS-CoV-2 virus from one human being to another is via the secretions of infected persons, mainly through direct contact with respiratory droplets of more than 5 microns (and which can be transmitted at distances of up to 2 metres). 29 Contact between the hands or contaminated fomites with the mucosa of the mouth, nose or eyes can constitute an a route of infection. The virus has also been detected in the saliva of infected patients, 30 which opens up the door to diagnosis via saliva samples. 31 The virus is known to be able to persist for up to 9 days 32 on certain surfaces (metal, plastic or glass), although it can be neutralised by means of the usual disinfection measures. The virus has been isolated in smaller droplets, and while the possibility of airborne transmission is still being debated, 33 have been demonstrated in closed and poorly-ventilated environments. 34 For these reasons, and while not all recommendations include measures for preventing airborne transmission, it is important to maintain good hygiene and suitable ventilation of all rooms. 35 The frequency of bowel involvement means that faecal transmission is a possibility. One recent review 36 shows that this has yet to be clarified, and that although there is no evidence of transmission, strict hygiene measures must be taken to prevent it. Vertical (mother-to-child) transmission seems somewhat unlikely, although some isolated cases have been published. 37 The presence of the virus in the semen of a small group of patients has been demonstrated, albeit only in the initial days of convalescence. 38 Nevertheless, sexual transmission seems somewhat unlikely. 39 One important problem in the prevention of this disease is the possible transmission by asymptomatic individuals. The median incubation period is 5-6 days, with a range of 1-14 days, although 97.5% of symptomatic cases develop within 11.5 days following exposure. 40 It has been shown that asymptomatic individuals can transmit the infection, 41 which makes it necessary to be very strict with the preventive measures and requires the development of detection policies for these potentially contagious individuals. With regard to the transmission capacity of symptomatic patients, it has been seen that most of those infected have a high viral load before and during the first few days after the onset of symptoms. 42 In patients with mild clinical symptoms, viral load is low as of the second week following the appearance of the symptoms, there being little likelihood of their transmitting the infection at that point, even although the virus can be detected with microbiology techniques (PCR). 43 In this way, transmission would mainly occur in the first week after the onset of symptoms (between days 2 and 3 and days 7 and 8) in mild cases. In more severe cases, transmission would be more intense and longer lasting. 4 In view of the above, the preventive measures with regard to staff are based on: • Establishing barriers (distance or physical barriers) between people. The basic measures would be the safety distance (2 metres) and the use of face masks. When dealing with infected or possibly infected patients, the use of personal protective equipment (PPE). • Hygiene. Hand sanitisation is the simplest and most effective way of preventing the transmission of microorganisms, including SARS-CoV-2. 44 Washing the hands with soap and water will suffice (there is no need to use antibacterial soaps), rubbing the hands for at least 40-60 seconds. Hydroalcoholic hand sanitisers are an alternative for quick disinfection although they should only be used once the hands are clean. • Identifying infected patients and possible carriers. In the case of symptomatic patients, it is easier to comply with the measure.: However, it is important to maintain a detection policy for asymptomatic carriers and to avoid any possible exposure. The policies put in place may vary from one site to another, although, generally speaking, carrying out tests on all workers is recommended, 45 as is enforcing certain measures that will make it possible to identify potentially infected persons when they come to the radiology department. Diagnosis of Covid-19 infection is based on the direct or indirect detection of the virus. 46 Microbiological and laboratory tests have improved in terms of sensitivity and specificity, although results must be interpreted with caution in view of the possibility of false negatives and false positives. Imaging tests are of great value in the management of patients with Covid-19 infection, as will be seen in forthcoming articles in RadiologÍa, although their usefulness in the initial diagnosis is limited to specific cases (mainly patients with a high suspicion and negative laboratory tests, or cases in which a quick diagnosis is required and no laboratory tests are available). 47, 48 Safe management of the Radiology department in the Covid era Fig. 4 is an infographic that summarises the main measures that should be taken in a radiology department to guarantee a safe working environment. It is a general document that can be applied both to a pandemic situation and to situations with a low prevalance of the disease, but in which safety measures must still be taken. Some of the measures that must be addressed are listed below. Personal Protective Equipment (PPE): these are barrier systems that should be used by staff to minimise the risk when studying a patient with conformed or suspected Covid-19 infection. Certain basic measures (specific clothes, surgical face masks, caps and gloves ---if deemed necessary) are used to establish three levels of protection according to the risk 50 : 1 First level (areas with possible contact with patients). 2 Second level (when there is going to be contact with patients). 3 Third level (when aerosols may be produced). It is important to remember that both the recommendations and the material used may change, so the latest guidelines of the Spanish Ministry of Health or the local Ministries of Health should be checked. Table 1 includes the recommended measures at the time this document was drafted. Face masks: the use of face masks has become widespread as the Covid-19 pandemic has advanced. At the time of writing this document, face coverings are obligatory for patients and health staff alike. Structural measures: in coordination with the corresponding organic and functional manager, and consisting basically of: • Adapting waiting rooms to make sure that the minimum distance is guaranteed (2 metres, or 1.5 metres if patients are wearing face masks). • Mark out corridors and safe zones. • Adequate signage. • Partitions and isolation measures for administrative staff. • Among the staff: ensure suitable distribution of workstations; facilitate non-attendance-based radiology, with appropriate shifts; define a policy for the use of common rooms; avoid visits from staff from other departments (telephone inquiries, virtual meetings, etc.). • Reduce the number of people having to go to the department (staggered appointments, one-off tests, ask patients not to come accompanied but, if they do, never by more than one person, etc.). They should be adapted to the situation (prevalence) at all times. The main measures that should be taken in a radiology department to guarantee a safe working environment. Observations: • If certain items of equipment are not available, the preceding one on the scale should be used. • If surgical masks are not available, a face shield may be used, which offers sufficient protection against droplet transmission. • A disposable gown may be used over the waterproof gown so that the waterproof gown can be reused. • Personalise workstations, making sure that staff do not share material. Clean all workstations thoroughly at the beginning and the end of shifts. • Use disposable gloves when shared equipment is to be handled (such as workstations). • Prohibit food or eating at workstations. Use only disposable containers for drinks. • Wear clean uniforms for each shift. Do not take used clothes home to wash. By reviewing the patient's medical record, performing diagnostic tests or specific questionnaires, 51 depending on the situation or the level of infection in the community. Some protocols include the performance of analytical tests (PCR) prior to surgical procedures or interventions, although these protocols are variable. In any event, these procedures should never replace personal protective measures, in view of the possibility of false negatives in laboratory tests. 52 Generally speaking, performing radiological tests (CT scan or chest X-ray) is not recommended as a screening method of asymptomatic patients, 53 particularly in low-prevalence situations. In a high prevalence environment, the CT scan could be justified on account of its high negative predictive value in situations in which a quick decision needs to be taken and no accessible laboratory tests are available. There are no analyses that demonstrate this measure is costeffective. 54 All radiology department staff should be tested to ascertain their immune status. A substantial percentage of workers are known not to be infected by patients but rather by colleagues. 55 The most susceptible staff should be relocated to suitable and low-risk work areas. 56 All the above measures and recommendations will call for a redesign of the imaging process. Some recommendations about this adaptation are provided by way of a summary in Table 2 . Impact on budget control. The economic crisis produced by Covid-19 infection is so important that some specialists regard it as the most important one since the World War II, although the reduction in gross domestic product per capita is the most widespread since 1870, due to the number of countries affected. 57 Hospitals and radiology departments have been affected by this crisis, facing increased costs (safety measures), reduced production and, at private centres, reduced billing. Profitability will be impacted in all cases due to the costs of producing studies not ultimately conducted. An analysis performed in the USA 58 pointed to a reduction in billable activity of between 50% and 70%, with a simultaneous increase in expenditure. In the initial stages of the crisis, it was estimated that this unfavourable situation Report chest X-rays The chest X-ray report can be useful for detecting unsuspected cases Test report Use preconfigured reports The use of template reports for X-rays and chest CT scans is recommended Test report Design teleradiology stations Teleradiology stations should be available to guarantee continued activity in the event of a high-prevalence situation could last for up to 9 months. This all means that it is important to monitor expenditure, coupled with good accounting management. Impact on training and research. The safety measures affect all the activities of the radiology department, including training, both training sessions and on-the-job training of students (medical students or higher-level diagnostic imaging technicians) and doctors in training (in radiology or other specialties). 59---62 In view of the economic impact of the crisis and its potential duration, it is important that all training programmes are maintained and that all departments establish, using the new technologies, measures to overcome the difficulties posed by the current situation. Hospital training activities (courses and congresses) have also been impacted 63 through the suspension of attendancebased activities and the development of online training activities. There is no consensus as to the possible mediumand long-term impact of the crisis on these activities, as this will depend on factors such as the development of a vaccine or the safety regulations that are applied. The Covid-19 crisis has also had an impact on research, particularly in processes not related to this infection. 64 Moreover, the crisis has generated scientific output at an unprecedented speed. This, which on the one hand has permitted key breakthroughs in a very short time, has also meant that in some cases editorial control has not been applied with the usual rigour, 65 sometimes having a big impact worldwide. 66 Risk management. Covid-19 infection is a threat to staff and patients and a core item in the way that a radiology department approaches its activity consists of good risk management, both prospectively and retrospectively. It is no different to other risk analyses, meaning that risk assessment studies will follow the same methodology. 67 Impact on structure. The latest report published by the Federación Española de Empresas de Tecnología Sanitaria [Spanish Federation of Medical Technology Companies] (FENIN) on medical technology 68 highlights the precarious situation of research into high-tech hospital equipment, which has accumulated a deficit since the crisis of 2008. The Covid-19 crisis has heightened this situation. Although many devices or equipment have been used less, in other cases they have been overused, and intensive cleaning and disinfection have affected some of them. For several months, the normal rhythm of machine maintenance has been altered. In this scenario, it is important that radiology departments have an updated plan addressing the situation of the equipment and renewal needs, supported by a clear rationale. Moreover, the first Covid-19 infection crisis has demonstrated the advantages of having direct portable conventional radiology equipment and portable ultrasound equipment. Radiology will play a key role in the management of the crisis, and for this it is essential that managers and politicians must comprehend the importance of maintaining reliable and safe technology. Impact on radiology professionals. The organisation of radiology departments has been greatly impacted by the Covid-19 crisis. During the pandemic, many departments have had to change their focus and dedicate their activities almost exclusively to the diagnosis of Covid-19. To this end, workforces have been restructured, both technicians and radiologists, with unequal working days and positions with different degrees of healthcare pressure. As the pressure of the Covid-19 infection decreases, organisations are returning to normal, but the need to maintain certain safety measures renders it necessary to reinforce certain aspects of healthcare that were not envisaged in initial staffing plans. Some examples include the need to bolster technical personnel for jobs with greatest risk (operating portable devices for infected patients, radiology indirtyzones), or the need to adapt radiologists' workstations so they can continue to perform simple X-rays, which is considered essential. It is important to clearly define all the department's activities in each one of the Covid-19 infection stages (prevalence), in order to be able to adjust the resources available. Sometimes, these measures involve redesigning workstations and the functions of each position, adapting them to specific conditions. Statistical processing: N/A. 7 Literature search: PVS, ARC Critical review of the manuscript with intellectually significant contributions Approval of the final version A Novel Coronavirus from Patients with Pneumonia in China A novel coronavirus outbreak of global health concern Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Enfermedad por nuevo coronavirus, COVID-19. Situación actual Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19 publications: database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Potential effects of coronaviruses on the cardiovascular system: a review Genetic analysis tracks SARS-CoV-2 mutations in human hosts The SARS-CoV-2 outbreak: what we know Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options COVID-19: physiopathologie d'une maladie à plusieurs visages. La Revue de Médecine Interne Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine A pneumonia outbreak associated with a new coronavirus of probable bat origin A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronaviruse and SARS-CoV-2: A double-edged sword? Liver injury in COVID-19: The current evidence Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy COVID-19 and its implications for thrombosis and anticoagulation The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia Neurological manifestations of COVID-19: a systematic review COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons The trinity of COVID-19: immunity, inflammation and intervention Evidence for Gastrointestinal Infection of SARS-CoV-2 Abdominal imaging findings in COVID-19: preliminary observations Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology The SARS epidemic in Hong Kong: what lessons have we learned? Consistent detection of 2019 novel coronavirus in saliva Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Aerodynamic characteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals during COVID-19 outbreak Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant Airborne transmission of SARS-CoV-2: the world should face the reality Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Clinical characteristics and results of semen tests among men with coronavirus disease 2019 Sexual Health in the SARS-CoV-2 Era The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic Viral load of SARS-CoV-2 in clinical samples Virological assessment of hospitalized patients with COVID-2019 Microbiology for radiologists: how to minimize infection transmission in the Radiology department Instrucciones sobre la realización de pruebas diagnósticas para la detección del COVID-19 Interpretación de las pruebas diagnósticas frente a SARS-CoV-2 The role of chest imaging in patient management during the COVID-19 pndemic: a multinational consensus statement from the Fleischner society SERAM. Guía básica de indicaciones de pruebas de imagen en la infección COVID-19 Rovira Cañellas A., Martínez Serrano C. La radiología desde la aparición de la infección COVID-19. Análisis y recomendaciones Prevention and control measures in radiology department for COVID-19 The Canadian Association of Radiologists (CAR) and the Canadian Society on Thoracic Radiology (CSTR) Recommendations on COVID-19 Management in Imaging Departments Interpreting diagnostic tests for SARS-CoV-2 Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis Chest CT and coronavirus disease (COVID-19): a critical review of the literature to date Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Procedimiento de actuación para los servicios de prevención de riesgos laborales frente a la exposición al SARS-CoV-2 Impacto socioeconómico de la pandemia de enfermedad por coronavirus de 2019-2020. Wikipedia, la enciclopedia libre The economic impact of the COVID-19 pandemic on radiology practices The impact of COVID-19 on medical education The impact of COVID-19 on radiology trainees Impact of COVID-19 on Canadian radiology residency training programs The impact of COVID-19 on interventional radiology training programs: what you need to know The impact of a pandemic on professional meetings Transitioning to a new normal after COVID-19: preparing to get back on track for cancer imaging Pandemic publishing: medical journals drastically speed up their publication process for Covid-19 RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis La gestión del riesgo en el ámbito de la radiología Perfil tecnológico hospitalario y propuestas para la renovación de tecnologías sanitarias The authors declare that they have no conflicts of interest.